文献速递临床试验与 GCP流行病学与生物统计

65岁及以上桡骨远端骨折患者非手术治疗与掌侧锁定钢板治疗的比较(DRIFT试验):一项随机对照试验

Nonoperative treatment versus volar locking plating for distal radius fracture in patients aged 65 years or older (DRIFT trial): A randomized controlled trial.
PubMed 文献 · PLoS Med · 2025-09-05

DRIFT试验在芬兰、瑞典和丹麦五个创伤中心纳入291例65岁及以上背侧移位的AO A型或C型桡骨远端骨折患者,闭合复位后对位不良者按1:1随机接受非手术治疗或掌侧锁定钢板治疗,主要结局为12个月患者腕关节评价(PRWE)。主要对位不良组PRWE平均效应为-9.6分(95%CI [-17.4, -1.7];p=0.0178),支持手术但小于预设最小临床重要差值11分;早期失去对位组为-6.2分(95%CI [-15.4, 3.0];p=0.1816)。

要点

  • 主要对位不良的桡骨远端骨折,掌侧锁定钢板治疗12个月PRWE平均效应-9.6分(95%CI [-17.4, -1.7];p=0.0178),小于预设最小临床重要差值11分。
  • 早期失去对位的桡骨远端骨折,手术12个月PRWE平均效应-6.2分(95%CI [-15.4, 3.0];p=0.1816),未达统计学显著。
  • 作者认为治疗方式的选择应在初始骨折复位后作出,后续监测骨折对位对预期腕关节功能无额外获益。

核心结论

  • 对主要对位不良的桡骨远端骨折,掌侧锁定钢板手术可能轻度改善12个月腕关节功能,但组间估计平均差值小于预设PRWE最小临床重要差值11分。
  • 对早期失去对位的桡骨远端骨折,手术治疗似乎不提供获益。
  • 作者认为治疗方式的选择应在初始骨折复位后作出,因为后续监测骨折对位对预期腕关节功能无额外获益,这使非手术治疗期间早期影像学随访的必要性受到质疑。

研究设计与样本

  • DRIFT试验为前瞻性、多中心、随机对照试验,在芬兰、瑞典和丹麦五个创伤中心开展。
  • 纳入65岁及以上、背侧移位的AO A型或C型桡骨远端骨折患者;闭合复位后未维持对位者按1:1随机接受非手术治疗或掌侧锁定钢板治疗;闭合复位后对位可接受者于复位后5-10天门诊随访,对位丢失者按1:1随机继续非手术治疗或接受掌侧锁定钢板治疗。
  • 2018年3月15日至2023年6月6日共纳入291例患者(平均年龄73岁(标准差5.8),女258例、男33例),12个月随访于2024年6月11日完成。
  • 主要对位不良组124例(非手术66例、掌侧锁定钢板58例);早期失去对位组86例(继续非手术44例、掌侧锁定钢板42例)。
  • 主要结局为12个月PRWE,主要分析采用线性混合模型,患者为随机因素,年龄和骨折关节内/关节外为固定因素;参与者和骨科研究者未设盲,统计师和负责分析的研究者在数据分析和得出结论期间保持盲态。

主要发现

  • 主要对位不良组12个月PRWE估计平均效应为-9.6分(95%CI [-17.4, -1.7];p=0.0178),支持掌侧锁定钢板,小于预设PRWE最小临床重要差值11分。
  • 早期失去对位组12个月PRWE平均效应为-6.2分(95%CI [-15.4, 3.0];p=0.1816)。
  • 12个月随访共发现25例治疗相关不良事件:主要对位不良组非手术10/66(15%)、手术5/58(8.6%);早期失去对位组非手术2/44(4.5%)、手术3/42(7.1%);对位良好组5/63(7.9%);另有11例其他不良事件。

关键数值与推荐

  • 主要对位不良组掌侧锁定钢板相对非手术的12个月PRWE估计平均效应为-9.6分(95%CI [-17.4, -1.7];p=0.0178)。
  • 早期失去对位组掌侧锁定钢板相对继续非手术的12个月PRWE平均效应为-6.2分(95%CI [-15.4, 3.0];p=0.1816)。
  • 预设PRWE最小临床重要差值为11分。

临床怎么用

  • 作者认为,对主要对位不良的桡骨远端骨折,掌侧锁定钢板手术可能轻度改善12个月腕关节功能,但差异小于预设最小临床重要差值11分。
  • 作者认为,对早期失去对位的桡骨远端骨折,手术治疗似乎不提供获益。
  • 作者建议治疗方式的选择应在初始骨折复位后作出,并认为后续监测骨折对位对预期腕关节功能无额外获益,对非手术治疗期间早期影像学随访的必要性提出质疑。

局限性

  • 试验招募期因全球COVID-19大流行相关限制而长于预期。
  • 由于纳入率下降,早期失去对位组在达到预设每组57例之前停止招募,这是该试验的主要局限性。
  • 参与者和骨科研究者未设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal management of distal radius fractures (DRFs) in older patients remains debatable. A knowledge gap exists concerning how to manage fractures with early malalignment during nonoperative treatment. We conducted a prospective, multicenter, and randomized controlled trial to compare nonoperative treatment to operative treatment with volar locking plating (VLP) in the management of primarily malaligned DRFs and DRFs that exhibit early malalignment during nonoperative treatment. METHODS AND FINDINGS: The DRIFT trial was conducted at five trauma centers in Finland, Sweden, and Denmark. Patients aged 65 years or older with a dorsally displaced AO-type A or C DRF were included in the trial. Patients with DRF who did not maintain alignment after closed reduction (CR) were randomized in 1:1 ratio to nonoperative treatment or VLP. Patients with acceptable alignment after CR visited the outpatient clinic 5-10 days after CR. If the alignment was lost, the patients were randomized in 1:1 ratio to either continue nonoperative treatment or to VLP. The primary outcome measure was Patient Rated Wrist Evaluation (PRWE) at 12 months. The primary analysis method for PRWE was a linear mixed model. In the linear mixed model, patient was a random factor and age and intra/extra articularity of the fracture were fixed. Participants and orthopedic investigators were not blinded. The statisticians and investigators responsible for the analysis remained blinded to the treatment groups during data analysis and the drawing of conclusions. Between March 15, 2018 and June 6, 2023, 291 patients aged 65 years or older (mean age 73 years (standard deviation (SD) 5.8), 258 women, 33 men) who had sustained a DRF were included in the trial. The 12-month follow-up was completed on June 11, 2024. One hundred twenty-four DRFs did not maintain acceptable fracture alignment after CR; 66 were randomized to nonoperative treatment and 58 to VLP. These patients are referred to as primarily malaligned DRFs. Eighty-six patients lost fracture alignment during the first 5-10 days of follow-up; 44 patients were randomized to continue nonoperative treatment, and 42 patients to VLP. These patients are referred to as early malaligned DRFs. In primarily malaligned DRFs, the estimated mean effect for PRWE at 12 months was -9.6 points (95% confidence interval (CI) [-17.4, -1.7]; p = 0.0178) in favor of VLP, which is smaller than the predefined minimal clinically important difference (MCID) of the PRWE (11 points). In early malaligned DRFs, the mean effect for PRWE at 12 months was -6.2 points (95% CI [-15.4, 3.0]; p = 0.1816). At 12-month follow-up, we found 25 treatment-related adverse events (AE) (10/66, 15% in primarily malaligned DRFs nonoperative; 5/58, 8.6% in primarily malaligned DRFs operative; 2/44, 4.5% in early malaligned DRFs nonoperative; 3/42, 7.1% in early malaligned DRFs operative; 5/63, 7.9% in well-aligned DRFs) and 11 other AE. The trial recruitment period was longer than expected due to the restrictions caused by the global COVID-19 pandemic. Due to the decreased inclusion rate, we had to cease the recruitment of patients with early malaligned DRF before reaching the predefined 57 patients per Arm, which was the main limitation of the trial. CONCLUSIONS: Operative treatment of primarily malaligned DRF with VLP may slightly improve wrist function at 12 months. The estimated mean difference between the groups was, however, smaller than the predefined MCID of the PRWE (11 points). In DRFs with early loss of alignment, operative treatment does not appear to provide benefit. Our results suggest that the choice of treatment modality should be made following primary fracture reduction because subsequent monitoring of fracture alignment does not offer any additional benefit in terms of expected wrist function. This questions the need for early radiographic follow-up during the nonoperative treatment. TRIAL REGISTRATION: The trial was registered at ClinicalTrials.gov (Identifier: NCT02879656, registration date 08/17/2016).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Hevonkorpi TP, Launonen AP, Reito A, et al. Nonoperative treatment versus volar locking plating for distal radius fracture in patients aged 65 years or older (DRIFT trial): A randomized controlled trial. PLoS Med. 2025. PMID: 40911648. doi:10.1371/journal.pmed.1004728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。